Login to Your Account

Pharma: Other News To Note

Friday, May 11, 2012
• Watson Pharmaceuticals Inc., of Parsippany, N.J., said that its subsidiary, Watson Laboratories Inc., filed an abbreviated new drug application with the FDA for Mesalamine delayed-release tablets 1.2 g.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription